Age Trends in Growth and Differentiation Factor-11 and Myostatin Levels in Healthy Men, and Differential Response to Testosterone, Measured Using Liquid Chromatography-Tandem Mass Spectrometry.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
01 04 2022
Historique:
received: 01 03 2021
pubmed: 27 5 2021
medline: 6 4 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

Growth and differentiation factor (GDF)-11 controls embryonic development and has been proposed as an antiaging factor. GDF-8 (myostatin) inhibits skeletal muscle growth. Difficulties in accurately measuring circulating GDF-11 and GDF-8 have generated controversy. We developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous measurement of circulating GDF-8 and GDF-11 that employs denaturation, reduction, and alkylation; cation-exchange solid-phase extraction; tryptic digestion; followed by separation and quantification using 2 signature peptides for multiple reaction monitoring and C-terminal [13C615N4]-Arg peptides as internal standards. We evaluated age trends in serum GDF-11 and GDF-8 concentrations in community-dwelling healthy men, 19 years or older, and determined the effects of graded testosterone doses on GDF-8 and GDF-11 concentrations in healthy men in a randomized trial. The assay demonstrated linearity over a wide range, lower limit of quantitation 0.5 ng/mL for both proteins, and excellent precision, accuracy, and specificity (no detectable cross-reactivity of GDF-8 in GDF-11 assay or of GDF-11 in GDF-8 assay). Mean ± SD (median ± 1QR) GDF-8 and GDF-11 levels in healthy community-dwelling men, 19 years and older, were 7.2 ± 1.9 (6.8 ± 1.4) ng/mL. Neither GDF-8 nor GDF-11 levels were related to age or body composition. Testosterone treatment significantly increased serum GDF-8 but not GDF-11 levels. The LC-MS/MS method for the simultaneous measurement of circulating total GDF-8 and GDF-11 demonstrates the characteristics of a valid assay. Testosterone treatment increased GDF-8 levels, but not GDF-11. Increase in GDF-8 levels by testosterone treatment, which increased muscle mass, suggests that GDF-8 acts as a chalone to restrain muscle growth.

Sections du résumé

BACKGROUND
Growth and differentiation factor (GDF)-11 controls embryonic development and has been proposed as an antiaging factor. GDF-8 (myostatin) inhibits skeletal muscle growth. Difficulties in accurately measuring circulating GDF-11 and GDF-8 have generated controversy.
METHODS
We developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous measurement of circulating GDF-8 and GDF-11 that employs denaturation, reduction, and alkylation; cation-exchange solid-phase extraction; tryptic digestion; followed by separation and quantification using 2 signature peptides for multiple reaction monitoring and C-terminal [13C615N4]-Arg peptides as internal standards. We evaluated age trends in serum GDF-11 and GDF-8 concentrations in community-dwelling healthy men, 19 years or older, and determined the effects of graded testosterone doses on GDF-8 and GDF-11 concentrations in healthy men in a randomized trial.
RESULTS
The assay demonstrated linearity over a wide range, lower limit of quantitation 0.5 ng/mL for both proteins, and excellent precision, accuracy, and specificity (no detectable cross-reactivity of GDF-8 in GDF-11 assay or of GDF-11 in GDF-8 assay). Mean ± SD (median ± 1QR) GDF-8 and GDF-11 levels in healthy community-dwelling men, 19 years and older, were 7.2 ± 1.9 (6.8 ± 1.4) ng/mL. Neither GDF-8 nor GDF-11 levels were related to age or body composition. Testosterone treatment significantly increased serum GDF-8 but not GDF-11 levels.
CONCLUSIONS
The LC-MS/MS method for the simultaneous measurement of circulating total GDF-8 and GDF-11 demonstrates the characteristics of a valid assay. Testosterone treatment increased GDF-8 levels, but not GDF-11. Increase in GDF-8 levels by testosterone treatment, which increased muscle mass, suggests that GDF-8 acts as a chalone to restrain muscle growth.

Identifiants

pubmed: 34037752
pii: 6284042
doi: 10.1093/gerona/glab146
pmc: PMC8974345
doi:

Substances chimiques

Growth Differentiation Factors 0
Myostatin 0
Testosterone 3XMK78S47O

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-769

Subventions

Organisme : NIA NIH HHS
ID : R01 AG052964
Pays : United States
Organisme : SBIR
ID : R44G045011
Organisme : NIA NIH HHS
ID : R56 AG052972
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Basic Res Cardiol. 2017 Sep;112(5):53
pubmed: 28721633
J Alzheimers Dis. 2018;62(2):807-819
pubmed: 29480172
Science. 2014 May 9;344(6184):649-52
pubmed: 24797481
Cell. 2013 May 9;153(4):828-39
pubmed: 23663781
Clin Chem. 2008 Nov;54(11):1855-63
pubmed: 18801940
Cell. 2010 Aug 20;142(4):531-43
pubmed: 20723755
J Gerontol A Biol Sci Med Sci. 2019 Jan 1;74(1):129-136
pubmed: 30380014
Mol Cell Endocrinol. 2012 Mar 5;350(1):39-52
pubmed: 22138414
Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60
pubmed: 24157714
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1258-70
pubmed: 19357233
FASEB J. 2015 Apr;29(4):1165-75
pubmed: 25466897
Steroids. 2009 Jun;74(6):512-9
pubmed: 19321131
Cell Metab. 2016 Jun 14;23(6):1207-1215
pubmed: 27304512
Annu Rev Cell Dev Biol. 2004;20:61-86
pubmed: 15473835
Am J Clin Nutr. 2002 Aug;76(2):378-83
pubmed: 12145010
Cardiovasc Res. 2005 Dec 1;68(3):347-9
pubmed: 16226233
JAMA. 2012 Mar 7;307(9):931-9
pubmed: 22396515
Circ Res. 2015 Nov 6;117(11):926-32
pubmed: 26383970
Circ Res. 2016 Apr 1;118(7):1125-41; discussion 1142
pubmed: 27034275
Dev Biol. 2004 Jun 1;270(1):19-30
pubmed: 15136138
Mech Dev. 2010 Sep-Dec;127(9-12):485-95
pubmed: 20807570
Cell Metab. 2015 Jul 7;22(1):164-74
pubmed: 26001423
N Engl J Med. 2004 Jun 24;350(26):2682-8
pubmed: 15215484
Aging Cell. 2016 Jun;15(3):582-4
pubmed: 27139744
Science. 2014 May 9;344(6184):630-4
pubmed: 24797482
Endocrinology. 2009 Mar;150(3):1259-68
pubmed: 18948405

Auteurs

Liming Peng (L)

Brigham Research Assay Core Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Thiago Gagliano-Jucá (T)

Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Karol M Pencina (KM)

Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Srinivasan Krishnan (S)

Billerica, Massachusetts, USA.

Zhuoying Li (Z)

Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Russell P Tracy (RP)

Larner College of Medicine, University of Vermont, Burlington, USA.

Ravi Jasuja (R)

Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Shalender Bhasin (S)

Brigham Research Assay Core Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Research Program in Men's Health: Aging and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH